Nonspecific effects in longitudinal studies: impact on quality of life measures.

[1]  A. Leplège,et al.  Analyse préliminaire des propriétés psychométriques de la version française d'un questionnaire international de mesure de qualité de vie : le MOS SF-36 (version 1.1). , 1995 .

[2]  R A Deyo,et al.  The importance of placebo effects in pain treatment and research. , 1994, JAMA.

[3]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[4]  C. Mulrow,et al.  Effects of Physical Therapy on Functional Status of Nursing Home Residents , 1993, Journal of the American Geriatrics Society.

[5]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[6]  S. Hercberg,et al.  Le projet SU.VI.MAX/100 000 volontaires pour la recherche en nutrition dans le domaine de la prévention , 1993 .

[7]  D. Spiegelhalter,et al.  Quality of life measures in health care. I: Applications and issues in assessment. , 1992, BMJ.

[8]  G Tomson,et al.  Randomization by group in studying the effect of drug information in primary care. , 1992, International journal of epidemiology.

[9]  Shephard Rj.  Long term impact of a fitness programme--the Canada Life Study. , 1992 .

[10]  C. Peck,et al.  Implications of placebo theory for clinical research and practice in pain management , 1991, Theoretical medicine.

[11]  I. Wiklund,et al.  Evaluation of quality of life in clinical trials. Selecting quality-of-life measures. , 1991, Controlled clinical trials.

[12]  R. Cebul.  Randomized, controlled trials using the Metro Firm System. , 1991, Medical care.

[13]  A. Feinstein,et al.  The qualification period. , 1991, Journal of clinical epidemiology.

[14]  I. Wiklund,et al.  Factors of importance when evaluating quality of life in clinical trials. , 1990, Controlled clinical trials.

[15]  G. Guyatt,et al.  Measuring quality of life in clinical trials: a taxonomy and review. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[16]  S. Chinn.  Longitudinal studies: design and analysis. , 1989, Revue d'epidemiologie et de sante publique.

[17]  R. J. Hayes,et al.  Methods for assessing whether change depends on initial value. , 1988, Statistics in medicine.

[18]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[19]  C. Bulpitt,et al.  Measurement of quality of life in clinical trials of therapy. , 1988, Cardiology.

[20]  W. Dixon,et al.  BMDP statistical software , 1983 .

[21]  R. Fletcher,et al.  Clinical Epidemiology: The Essentials , 1982 .

[22]  Harvey Goldstein,et al.  The Design And Analysis Of Longitudinal Studies , 1979 .

[23]  C. E. Davis,et al.  The effect of regression to the mean in epidemiologic and clinical studies. , 1976, American journal of epidemiology.

[24]  H. Parsons.  What Happened at Hawthorne? , 1974, Science.

[25]  A. Shapiro.  FACTORS CONTRIBUTING TO THE PLACEBO EFFECT. THEIR IMPLICATIONS FOR PSYCHOTHERAPY. , 1964, American journal of psychotherapy.

[26]  F. J. Roethlisberger,et al.  Management and the Worker , 1941 .